Cytotoxic T cell recognition of virus-infected cells requires the presentation of viral peptides by class I HLA molecules on the cell surface. We report here that cytomegalovirus (CMV) infection of human fibroblasts results in a progressive decrease in the cell surface expression of class I HLA and fl2-microglobulin (fl2m) such that in the late stages of infection the majority of infected cells have no detectable surface class I HLA. Coincident with decreased surface expression of class I HLA was an increase in his cytoplasmic expression. Confocal scanning laser microscopic analysis demonstrated that class I HLA and fl2m accumulate in a perinuclear compartment inside the CMV-infected cell. Our data thus support the concept that CMV infection induces altered transport of class I HLA to the cell surface. We suggest that the virus has evolved this mechanism as a strategy to avoid T cell recognition of infected cells.
Introduction
Cytomegalovirus (CMV) is an important pathogen in the immunocompromised host or the immunologically immature foetus, whereas infection of immunocompetent individuals is usually asymptomatic, suggesting that the normal host response is protective. However, even the immunocompetent host fails to eradicate the virus following primary infection, and CMV establishes latency. Several mechanisms by which CMV could evade the host immune response have been proposed (reviewed in Grundy, 1991) , including the binding of non-neutralizing antibody or host fl2-microglobulin (fl2m) to the virus particle, antigenic variation amongst CMV strains, and the induction of Fc receptors on the surface of CMVinfected cells. The former three properties of CMV would be expected to help evade neutralization of free virus by antibody, whereas the latter would facilitate the evasion of antibody-mediated lysis of infected cells. However, little attention has been paid to mechanisms by which CMV might evade cell-mediated immunity.
Cytotoxic T cell recognition of virus-infected cells requires presentation of viral peptides to the T cell receptor by major histocompatibility complex (MHC) antigens on the infected cell surface. Class I MHC molecules, products of the HLA loci in man, present peptides to CD8-positive T cells, the predominant cytotoxic T cell phenotype, although CD4-positive cytotoxic T cells which recognize peptide in association with class II MHC molecules have been described (Lindsley et al., 1986 ). In addition, T cell recognition of infected cells requires the interaction between cell surface adhesion molecules and their respective ligands on the T cell and target cell. Alterations in the level of expression of either class I HLA molecules or cell surface adhesion molecules during virus infection might thus affect T cell recognition of infected cells.
We have previously reported enhanced expression of class I HLA antigens in cultures of human fibroblasts infected at a low level with CMV compared to uninfected fibroblasts (Grundy et al., 1988) . However, this enhancement can be significantly decreased by the addition of a neutralizing antibody against fl-interferon (Grundy et al., 1988) , suggesting that interferon released from infected cells is responsible for up-regulating the expression of class I antigens on uninfected cells in culture. We have investigated the effect of CMV infection on class I HLA expression on the infected cell surface, and the results, previously presented in abstract form (Barnes et al., 1990a, b; Hutchinson et al., 1991) , are reported here. The effect of CMV infection on the expression of cell surface adhesion molecules is described elsewhere (Downes & Grundy, 1992; Hutchinson et al., 1991) .
Virus preparations. CMV strain AD169 was harvested from the culture medium of fibroblasts grown in the presence of 4% FCS, clarified by centrifugation at 1500g for 20 min and stored at -70 °C until required. Virus stocks were titrated on fibroblasts cultured in slide chambers, and the percentage of cells expressing the 72K major immediate early protein at 24 h post-infection was determined by immunofluorescence (see below) using the monoclonal antibody (MAb) 63.27 (Andreoni et al., 1989) . This method compares favourably with classical TCIDso assays. By using this assay the minimum dose that resulted in infection of 100% of cells was determined [minimum infectious dosejoo (MIDL00)].
CMV infection offibroblasts. Fibroblasts were seeded at 4 x 10 a cells/well in slide chambers, or at 1.4 x l06 cells/75 cm 2 flask, and cultured for 24 h as above. The medium was removed from the wells/flasks and the cells were washed with PBS before addition of the appropriate dilution of CMV strain AD169, or medium containing 4~ FCS. After adsorption of the virus for 1 h at 37 °C, the inoculum was removed, the cells were washed in PBS and medium containing 4% FCS was added.
Source of MAbs and antibody conjugates. Hybridoma lines secreting
the murine MAbs W6/32 and PA2.6, specific for the class I HLA heterodimer (Brodsky & Parham, 1982) , and BBM. 1 (Brodsky & Parham, 1982) and L368 (Lampson et al., 1983) , specific for fl2m (both free and bound to the class I HLA ct chain), were obtained from the ATCC; MAb C21, specific for free but not HLA-bound fl2m (Liabeuf et al., 1981) , was a kind gift from Dr A. Sanderson. Hybridomas secreting murine MAbs 63.27, specific for the 72K major immediate early protein of CMV (Andreoni et al., 1989) , and 7.17, specific for the CMV envelope glycoprotein B (gB; Britt & Auger, 1986) , were both kindly provided by Dr W. Britt. An F(ab')2 fraction of a rabbit antimouse antibody labelled with fluorescein isothiocyanate (FITC) was obtained from Serotee. RFDI, a biotinylated mouse MAb specific for dendritic cells, was obtained from the Immunology Department of the Royal Free Hospital School of Medicine. Streptavidin-rhodamine and streptavidin-phycoerythrin conjugates were obtained from Seralab and Biotec, respectively.
Purification and biotinylation of antibodies. MAbs W6/32, PA2.6, BBM. 1 and L368 were prepared from the culture supernatant of the appropriate hybridomas by ammonium sulphate fractionation. MAbs 63.27 and 7.17 were affinity-purified from ascitic fluid using Protein A-Sepharose (Pharmacia) according to the manufacturer's instructions. The affinity-purified MAbs were adjusted to a concentration of 1 mg/ml in 0.1 M-NaHCO3, and reacted for 4 h at ambient temperature with N-hydroxysuccinimidobiotin (1 mg/ml; Sigma) in DMSO (Sigma) at a ratio of 120~tl/mg antibody. The antibody mixture was then dialysed overnight against PBS at 4 °C to remove any unbound biotin, and stored at 4 °(2 in 0.1% sodium azide prior to use.
Immunofluoresce~e staining of cell monolayers. Fibroblast monolayers in slide chambers were washed with PBS, dried in air, fixed in acetone at -20 °C for 5 min and stored at -20 °C. Slides were thawed, washed with PBS, and the first layer antibody (specific for class I HLA, fl2m or CMV proteins) was added to each well before incubation at 37 °C for 1 h in a humid chamber. The slides were washed for 5 min in PBS and then 30 ~tl of the FITC-labelled rabbit anti-mouse antibody or, in the case of the biotinylated antibodies, streptavidin-rhodamine was added. This second layer was incubated for 45 min in the dark at 37 °C in a humid chamber. The slides were then washed with PBS for 5 min, dried in air and mounted using Citifluor. If the slide was simultaneously stained for HLA/fl2m and CMV antigens (the double-staining protocol), the first layer was always anti-HLA/fl2m antibody and the second layer was the FITC-labelled rabbit anti-mouse antibody. The slides were then incubated for 20 min at room temperature with a third layer, normal mouse serum. The slides were washed for 5 min and then stained with the fourth and fifth layers, which were one of the biotinylated anti-CMV antibodies and the streptavidin-rhodamine conjugate, respectively. The staining protocol for the fourth and fifth layers was the same as that for the first and second layers. The slides were then washed, mounted and stored as above.
Photomicrography and confocal scanning laser microscopy. Slides were examined using an Olympus BH2 epifluorescence microscope with appropriate filters for fluorescein and rhodamine excitation and emission. Photomicrographs were taken using an Olympus OM-2 camera and Kodak Tmax 400 ASA professional film. Alternatively, the cells were examined using a Bio-Rad MRC 600 confocal scanning laser microscope, which allowed the collection of fluorescent emisssions from serial optical sections in an x-y plane from the top to the bottom of the cell, or the simultaneous collection of phase-contrast and emitted fluorescence profiles.
Flow cytometry. Fibroblasts were cultured in flasks and infected with CMV as described above. At relevant times post-infection, the cells were removed by trypsinization for exactly 5 min and washed twice by centrifugation at 1500 g for 12 min, before being resuspended in PBS. FCS was added before the first wash to halt the trypsinization reaction. The cell suspensions were filtered through nylon gauze to remove any aggregates, and divided so that each sample contained 1 x 106 cells in 50 ~tl of PBS. Immunofluorescence staining was performed by incubating the cells with each of the antibodies in the order described for the slides, except that streptavidin-phycoerythrin was used in place of streptavidin-rhodamine for the biotinylated antibodies. The cells were washed between the addition of each layer by centrifugation at 1300g for 5 min followed by resuspension in PBS with 0-1% BSA, azide and ethanol. When the staining was complete, the cells were fixed with 4% formaldehyde before analysis using a Coulter flow cytometer.
Results

Analysis of the effect of CMV infection on the expression of class I HLA and fl2m antigens on the cell surface
Fibroblasts cultured in flasks were infected with CMV strain AD169 and the cell surface expression of class I HLA and fl2m was analysed by flow cytometry daily from 1 to 6 days post-infection. It was not possible to perform double-labelling experiments with antibodies to class I HLA/fl2m and CMV late proteins because we were unable to detect significant levels of CMV gB on the surface of CMV-infected cells by flow cytometry under the conditions used. Therefore, to ensure that any effects observed were on CMV-infected cells, and not due to bystander effects on any uninfected cells in the culture, we performed experiments at two m.o.i.s, using a dose of virus that initially infected 100% of the cells (high virus dose, 2 × MID100) and a 10-fold lower dose that resulted in 100% infection by day 6. Expression of the class I heterodimer was monitored using MAb PA2.6, (b, e and h) whereas for fl2m, MAb L368 was used (c, fand i). MAb C21 (a, d and g) was included as a negative antibody control. For both the class I HLA heterodimer and fl2m, the number of positive cells (% POS) and the mean fluorescence intensity (MFl)/cell were decreased following infection with either virus dose.
I HLA and fl2m. The mean number of cells positive for these antigens, and the mean fluorescent intensity of those cells, were both markedly reduced. This effect was more pronounced with the higher virus dose. Although the results shown were obtained using MAb PA2.6 for class I HLA and L368 for fie m, identical results were obtained in this and subsequent experiments using MAbs W6/32 and BBM. 1 for class I HLA and f12 m respectively. MAb C21, which detects only free and not HLA-bound flzm, gave negative results on the surface of both infected and uninfected cells, as expected. Fig. 2 shows the expression of cell surface class I HLA and flzm on various days post-CMV infection. Both class I HLA and flzm expression progressively decreased on the surface of infected cells, so that by day 6 postinfection these antigens could only be detected on 14% and 27% of infected cells, respectively, at the higher virus dose (Fig. 2a, b) . The intensity of class I HLA and fl2m expression decreased from 24 h post-infection at the higher virus dose (Fig. 2c, d ), so that by day 4 levels of these antigens on the surface of infected cells were only about 20% of that of uninfected cells. Similiar data were obtained in experiments using virus doses from 1 x to 4 x MID100. At the 10-fold lower virus dose, class I HLA and fl2m expression remained around normal until day 3 post-infection, after which it declined rapidly, presumably reflecting the lag time required for infection of all cells in the culture at this dose.
Effect of CMV infection on the expression of class I HLA and f12 m in permeabilized cells
To determine whether CMV infection also resulted in a decreased expression of class I HLA and fl2m in the cytoplasm of infected cells, the expression of these antigens and CMV proteins was studied in permeabilized cells using the single immunofluorescence protocol. Fibroblasts cultured in slide chambers were infected with CMV strain AD169 (2 x MIDloo) and fixed at daily intervals until 6 days post-infection when 100% c.p.e. was seen.
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In marked contrast to the results obtained by flow cytometry for cell surface expression, there was a progressive increase with time in the expression of both class I HLA and fl2m in permeabilized cells from an infected culture. This could be observed from days 2 to 3 onwards, and maximal expression was seen 6 days postinfection, coinciding with the expression of the CMV late protein gB. Fig. 3 illustrates the results for the class I HLA heterodimer, and shows the intense expression of class I HLA in permeabilized cells 6 days post-infection (Fig. 3 a) compared to the low level of expression seen in uninfected cells (Fig. 3b ) when both were examined under the same laser excitation intensity and over the same scanning interval with the confocal scanning laser microscope.
The distribution of class I HLA in the cells from the infected culture appeared to be predominantly localized to a perinuclear area (Fig. 3a) , whereas if the laser intensity was increased to visualize the antigen distribution in the uninfected cells, diffuse distribution was observed (Fig. 3 c) . The distribution of the intense class I HLA expression seen in the permeabilized cells from the infected cultures was studied further by optically sectioning the cell using the confocal scanning laser microscope. Serial optical sections in an x-y plane from the top to the bottom of the cell demonstrated that class I HLA antigens had accumulated in the cytoplasm of the infected cell, in a perinuclear compartment most likely representing the Golgi complex (Fig. 4) .
Double labelling for class I HLA/fl2m antigens and CMV proteins in permeabilized fibroblasts
The cells from infected cultures showing an increase in class I HLA and fl2m antigen expression exhibited the expected morphology of CMV-infected fibroblasts, with cell rounding and an indented kidney-shaped nucleus, rather than the spindleform morphology of uninfected cells. However, to confirm that the cells showing the increase in perinuclear expression of class I HLA and fl2m were virus-infected, fibroblasts from infected cultures were simultaneously examined for the expression of class I HLA and fl2m using the double-labelling immunofluorescence protocol. These studies were performed 6 days post-infection when CMV and class I HLA/fl2m have been shown to be maximally coexpressed. Fig. 5 shows that the cells demonstrably infected with CMV, i.e. is expressing CMV late proteins (Fig. 5a, c) , also showed intense perinuclear accumulation of class I HLA and fl2m antigens ( Fig. 5b and d , respectively). Double labelling of cells was not observed when an irrelevant biotinylated antibody was used instead of the CMV-specific antibody (data not shown).
The enhanced expression of class i HLA and f12 m observed in the cytoplasm of the infected cells was not an optical artefact resulting from the altered morphology of the infected cells because trypsinized uninfected cells, which also adopt a rounded morphology similar to that of infected cells, failed to show a similar enhancement of cytoplasmic class I HLA and fl2m when examined as cytospin preparations (data not shown).
Discussion
Our results clearly demonstrate that CMV induces a progressive decrease in the expression of class I HLA on the surface of infected cells. Identical results were obtained with antibodies specific for the class I HLA heterodimer and antibodies specific for fl2m. Levels of cell surface class I HLA declined from 24 h postinfection, such that by days 5 to 6 few infected cells had demonstrable surface class I HLA, and the level of expression on the positive ceils was reduced to about 20 ~o of that observed on uninfected cells.
The down-regulation of cell surface class I HLA induced by CMV is dose-dependent. Virus doses that resulted in initial infection of 100 ~o of the cells induced a rapid loss of class I HLA on the majority of the cells, whereas 10-fold lower doses, which resulted in 100~o infection by day 6 post-infection, were accompanied by a delayed and less severe decrease in class I HLA expression. Our previous studies using virus doses that infect only 10~ of cells have shown that interferon released from infected cells induces an overall upregulation of class I HLA (Grundy et al., 1988) , which we concluded was on the uninfected cells which predominated in these cultures. Thus it is important to distinguish between the effect on the infected cell itself and the bystander effect mediated by cytokines on uninfected cells in the culture. Others have described an upregulation of class I HLA on the surface of endothelial cells in infected cultures compared to cells from P. D. Barnes and J. E. Grundy Fig. 4 . The intracellular location of enhanced expression of class I HLA observed in permeabilized cells from a CMV-infected culture examined by optically sectioning the cells shown in Fig. 3 (a) using the confocal scanning laser microscope. Serial optical sections I ktm apart were taken from the top (upper left panel) to the bottom (lower right panel) of the cells. The images clearly show that following CMV infection, the class I HLA heterodimer accumulates in the perinuclear area of the cytoplasm. uninfected cultures (van Dorp et al., 1989) . However, in these studies only about 10 ~ of the endothelial cells were infected, and it could not be determined from the data presented whether the increased class I H L A expression was actually on the infected endothelial cells or on bystander uninfected cells in the same cultures.
In marked contrast to the down-regulation of class I H L A on the surface of CMV-infected fibroblasts, we found that infected cells had extremely high levels of expression of class I H L A and fl2m in the cytoplasm when compared to uninfected cells. In addition, the diffuse distribution of class I H L A observed in the cytoplasm of uninfected fibroblasts was found to be dramatically altered following C M V infection, when class I H L A antigens appeared to accumulate in the perinuclear area. Studies of the intracellular distribution of class I H L A molecules in the infected cell by confocal scanning laser microscopy confirmed that class I H L A was not detectable at the cell surface but was found in dense accumulations at levels deep within the cell, in a compartment probably representing the Golgi body. The double-labelling immunofluorescence studies suggested that in infected cells, class I H L A co-localizes with C M V gB, further suggesting that class I H L A accumulates in the Golgi body.
The simultaneous finding of decreased surface expression of class I H L A and increased cytoplasmic expression suggests that class I H L A molecules are not properly transported to the cell surface after C M V infection of fibroblasts. In additional studies ( D o w n e s & Grundy, 1992; Hutchinson et al., 1991) , we have shown that other cell surface molecules such as ICAM-1 and LFA-3 are increased following C M V infection, suggesting that the failure to transport class I molecules to the cell surface is not a general consequence of the pathological effects of C M V on the cell. It is possible that such altered transport of class I H L A might be due to the failure in infected cells of the class I H L A ~ chain and fl2m to associate with each other and form the class I heterodimer. However, the observed cytoplasmic accumulations of class I H L A and fl2m were reactive with antibodies specific for conformational determinants on the class I heterodimer (MAbs W6/32 and PA2.6), and identical results were obtained using antibodies specific for the class I HLA heterodimer and those reactive with free or HLA-bound fl2m (MAbs BBM. 1 and L368). This suggests that the class I HLA chain and fl2m do associate into the heterodimer in the cytoplasm of the CMV-infected cell. Thus, our data suggest that some other mechanism is responsible for the altered transport of class I HLA molecules in CMVinfected cells.
Our findings conflict with those of others (Browne et al., 1990) , who have concluded that there is decreased translation of class I HLA following CMV infection, based on evidence from immunoprecipitation experiments with metabolically labelled cells. Clearly, our study demonstrates that class I HLA progressively accumulates in the cytoplasm of infected cells after CMV infection, which suggests that the constituent proteins are still being produced. Indeed, our preliminary experiments demonstrate that more metabolically labelled class I HLA and f12 m can be immunoprecipitated from CMV-infected cells than from uninfected cells at both early and late times after infection (M. R. Gopal & J. E. Grundy, unpublished observations). Thus, the reasons for the disparity between our results and those of Browne et al. (1990) are not clear, but may reflect differences in different cell lines.
It is possible that the down-regulation of class I HLA on the surface of cells infected with CMV may have important consequences for cytotoxic T cell recognition of infected cells, so that at late stages of infection there may be insufficient class I HLA to present peptides from late proteins to T cells. Indeed, it has previously been shown in both man (Borysiewicz et al., 1988a, b) and mouse Koszinowski et al., 1987) that the predominant cytotoxic T cell target is the CMV immediate early gene product. However, when late gene products such as gB are expressed in recombinant vaccinia viruses, they can act efficiently as targets for cytotoxic T cell recognition (Borysiewicz et al., 1988b) . Thus it is possible that in natural infections the cytotoxic T cell response is predominantly directed to immediate early gene products because the altered transport of class I HLA molecules, demonstrated here to occur at later stages of infection, may reduce the ability of late gene products to act as T cell targets. Indeed, data has been presented which suggest that CMV infection can alter the presentation of influenza virus peptides to cytotoxic T cells (L. K. Borysiewicz, British Society for Immunology Meeting, April 1990).
Down-regulation of class I HLA as a mechansim of evading cytotoxic T cell recognition has previously been proposed for adenovirus (Burgert et al., 1987; Andersson et al., 1985; Signas et al., 1982) . Adenovirus type 2 encodes a 19K glycoprotein from the E3 region which binds to the ct chain of class I HLA in infected cells, preventing its terminal glycosylation and subsequent transport to the cell surface. Thus, class I HLA accumulates in the cytoplasm, and cell surface expression is reduced, in adenovirus 2-infected cells. Transfection of the E3 region results in decreased class I HLA (to levels 30 to 50~ of normal) and a reduction in the ability of cells to be lysed by cytotoxic T cells (Burgert et al., 1987) . Thus it should be noted that the extent of the reduction in surface class I HLA induced by adenovirus 2 associated with functional effects on T cell recognition is similar to or less than that induced by CMV, supporting a probable functional effect in the case of CMV. Adenovirus 12 adopts a different strategy to reduce surface class I HLA (Schrier et al., 1983) ; the E 1 a gene is responsible for decreased transcription of the class I HLA ct chain.
Our findings with CMV resemble more closely the situation with adenovirus 2 because we have observed cytoplasmic accumulation of class I HLA. It is of interest in this regard that whereas an adenovirus protein binds the class I HLA ~ chain (Andersson et al., 1985; Signas et al., 1982) , we have previously shown that CMV binds the class I HLA light chain, fl2m . The viral proteins responsible for this effect have not been characterized, although the CMV genome encodes a class I HLA homologue (Beck & Barrell, 1988) , UL18, which, when expressed in recombinant vaccinia viruses, has been shown to bind flzm (Browne et al., 1990) . However, a protein product of this gene has not yet been demonstrated on the virus particle or in infected cells. Furthermore the down-regulation of class I HLA described here was seen from 24h post-infection, whereas it might be expected that the UL18 gene product, like most CMV glycoproteins, would not be expressed until late stages of replication. Thus, whether the altered transport of class I HLA in CMV-infected cells is due to the binding of fl2m by viral proteins in the cytoplasm, and the identity of these binding proteins, has still to be determined. Interestingly, when cells are coinfected with recombinant vaccinia viruses carrying the UL18 and the human fl2m genes, expression of cell surface fl2m (measured using MAb BBM. 1) has been found to be increased compared to that in cells infected with the construct carrying the fl2m gene alone, suggesting increased transport of fl2m to the cell surface in the presence of the UL18 protein (Browne et al., 1990) . However, in our studies cell surface fl2m detectable with this antibody is significantly reduced on infected cells, suggesting that f12 m is probably not expressed on the cell surface in association with the UL18 product following natural CMV infection.
In conclusion, we have shown that CMV induces a dose-dependent down-regulation of cell surface class I HLA from 24 h post-infection, such that class I HLA antigens are virtually absent from the majority of cells at late stages of infection. This occurs simultaneously with cytoplasmic accumulation of class I HLA in the perinuclear area of the cell, suggesting that CMV alters transport of class I HLA to the cell surface. The mechanism responsible for this effect remains to be determined, but it is possible that CMV has adopted this strategy as a means of evading cytotoxic T cell recognition of infected cells.
